Literature DB >> 7964847

Gangliosides and autoimmune neuropathies: classification and clinical aspects of autoimmune neuropathies.

A J Steck1, L Kappos.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7964847      PMCID： PMC1016719          DOI： 10.1136/jnnp.57.suppl.26

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  17 in total

1.  Serum IgG antibody to ganglioside GQ1b is a possible marker of Miller Fisher syndrome.

Authors:  A Chiba; S Kusunoki; T Shimizu; I Kanazawa
Journal:  Ann Neurol       Date:  1992-06       Impact factor: 10.422

2.  Predictive value of anti-GM1 ganglioside antibodies in neuromuscular diseases: a study of 180 sera.

Authors:  D Adams; T Kuntzer; D Burger; M Chofflon; M R Magistris; F Regli; A J Steck
Journal:  J Neuroimmunol       Date:  1991-06       Impact factor: 3.478

Review 3.  Invited review: motor neuropathies, motor neuron disorders, and antiglycolipid antibodies.

Authors:  A Pestronk
Journal:  Muscle Nerve       Date:  1991-10       Impact factor: 3.217

Review 4.  Peripheral neuropathy associated with monoclonal IgM autoantibody.

Authors:  A J Steck; N Murray; K Dellagi; J C Brouet; M Seligmann
Journal:  Ann Neurol       Date:  1987-12       Impact factor: 10.422

5.  Measurement and significance of antibodies against GM1 ganglioside. Report of a workshop, 18 April 1989, Chicago, IL, U.S.A.

Authors:  D M Marcus; N Latov; B P Hsi; B K Gillard
Journal:  J Neuroimmunol       Date:  1989-12       Impact factor: 3.478

6.  Pathological findings at the site of conduction block in multifocal motor neuropathy.

Authors:  R Kaji; N Oka; T Tsuji; T Mezaki; T Nishio; I Akiguchi; J Kimura
Journal:  Ann Neurol       Date:  1993-02       Impact factor: 10.422

7.  High-dose intravenous immunoglobulin therapy in multifocal motor neuropathy.

Authors:  E Nobile-Orazio; N Meucci; S Barbieri; M Carpo; G Scarlato
Journal:  Neurology       Date:  1993-03       Impact factor: 9.910

8.  Serum antibodies to GM1 ganglioside in amyotrophic lateral sclerosis.

Authors:  A Pestronk; R N Adams; L Clawson; D Cornblath; R W Kuncl; D Griffin; D B Drachman
Journal:  Neurology       Date:  1988-09       Impact factor: 9.910

9.  Myelin-associated glycoprotein is the antigen for a monoclonal IgM in polyneuropathy.

Authors:  P E Braun; D E Frail; N Latov
Journal:  J Neurochem       Date:  1982-11       Impact factor: 5.372

10.  Reactivity with the peripheral myelin glycoprotein P0 in serum from patients with monoclonal IgM gammopathy and polyneuropathy.

Authors:  E Bollensen; A J Steck; M Schachner
Journal:  Neurology       Date:  1988-08       Impact factor: 9.910
View more
  5 in total

Review 1.  Diabetic neuropathy in older adults.

Authors:  Kara A Witzke; Aaron I Vinik
Journal:  Rev Endocr Metab Disord       Date:  2005-05       Impact factor: 6.514

Review 2.  Diabetic neuropathy in older adults.

Authors:  Aaron I Vinik; Elsa S Strotmeyer; Abhijeet A Nakave; Chhaya V Patel
Journal:  Clin Geriatr Med       Date:  2008-08       Impact factor: 3.076

Review 3.  Diabetic Microvascular Disease: An Endocrine Society Scientific Statement.

Authors:  Eugene J Barrett; Zhenqi Liu; Mogher Khamaisi; George L King; Ronald Klein; Barbara E K Klein; Timothy M Hughes; Suzanne Craft; Barry I Freedman; Donald W Bowden; Aaron I Vinik; Carolina M Casellini
Journal:  J Clin Endocrinol Metab       Date:  2017-12-01       Impact factor: 5.958

4.  Guillain-Barre syndrome in an adult patient with Henoch-Schonlein purpura.

Authors:  Puneet Aggarwal; Ratnakar Sahoo; A K Gadpayle; Gunjan Kumar
Journal:  BMJ Case Rep       Date:  2013-04-03

5.  Renal glycosphingolipid metabolism is dysfunctional in lupus nephritis.

Authors:  Tamara K Nowling; Andrew R Mather; Thirumagal Thiyagarajan; María José Hernández-Corbacho; Thomas W Powers; E Ellen Jones; Ashley J Snider; Jim C Oates; Richard R Drake; Leah J Siskind
Journal:  J Am Soc Nephrol       Date:  2014-09-30       Impact factor: 10.121
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.